INT222742

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.53
First Reported 2007
Last Reported 2010
Negated 1
Speculated 0
Reported most in Body
Documents 4
Total Number 9
Disease Relevance 12.09
Pain Relevance 3.03

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

cytosol (S100A12) extracellular region (S100A12) nucleus (S100A12)
cytoplasm (S100A12)
S100A12 (Homo sapiens)
Pain Link Frequency Relevance Heat
psoriasis 2 99.84 Very High Very High Very High
corticosteroid 12 99.82 Very High Very High Very High
Crohn's disease 210 99.00 Very High Very High Very High
Inflammatory marker 26 97.92 Very High Very High Very High
spastic colon 144 95.64 Very High Very High Very High
Infliximab 6 94.32 High High
Inflammation 170 93.20 High High
Piles 6 90.96 High High
Osteoarthritis 4 81.36 Quite High
Arthritis 4 79.92 Quite High
Disease Link Frequency Relevance Heat
Psoriasis 4 99.84 Very High Very High Very High
Inflammatory Bowel Disease 500 99.68 Very High Very High Very High
Disease 446 99.54 Very High Very High Very High
Ileitis 6 99.48 Very High Very High Very High
Skin Cancer 5 99.28 Very High Very High Very High
Colitis 14 98.88 Very High Very High Very High
INFLAMMATION 182 97.60 Very High Very High Very High
Melanoma 39 97.20 Very High Very High Very High
Irritable Bowel Syndrome /

Irritable Bowel Syndrome Super

126 95.64 Very High Very High Very High
Nicotine Addiction 78 94.52 High High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
This result is partly in accordance with an earlier study in which corticosteroids did not alter significantly S100A12 serum levels of IBD adults [8].
Neg (not) Regulation (alter) of S100A12 associated with inflammatory bowel disease and corticosteroid
1) Confidence 0.53 Published 2010 Journal BMC Gastroenterol Section Body Doc Link PMC2964606 Disease Relevance 1.75 Pain Relevance 0.31
Similarly, all treatment modalities, leading to a subsequent disease remission, did not seem to have a noticeable effect on serum levels of S100A12 in the IBD group.
Regulation (effect) of S100A12 associated with inflammatory bowel disease and disease
2) Confidence 0.45 Published 2010 Journal BMC Gastroenterol Section Body Doc Link PMC2964606 Disease Relevance 1.78 Pain Relevance 0.32
Is this interaction dependant on the oligomeric state of the S100 protein?
Regulation (dependant) of S100 protein
3) Confidence 0.29 Published 2009 Journal J Transl Med Section Body Doc Link PMC2666642 Disease Relevance 0.87 Pain Relevance 0.26
The median value of serum S100A12 levels was 68.2 ng/mL (range: 43.4-147.4) for UC patients and 70 ng/mL for CD patients (range: 41.4-169.8).
Regulation (value) of S100A12 associated with inflammatory bowel disease and crohn's disease
4) Confidence 0.27 Published 2010 Journal BMC Gastroenterol Section Body Doc Link PMC2964606 Disease Relevance 0.75 Pain Relevance 0.51
The median values of serum S100A12 levels were 68.2 ng/mL (range: 43.4-147.4) in UC, 70 ng/mL (41.4-169.8) in CD and 43.4 ng/mL (34.4-74.4) in IBS patients.
Regulation (values) of S100A12 associated with inflammatory bowel disease, crohn's disease and spastic colon
5) Confidence 0.27 Published 2010 Journal BMC Gastroenterol Section Abstract Doc Link PMC2964606 Disease Relevance 1.68 Pain Relevance 0.91
Similarly, by relying on S100A12 serum levels, disease location could not be predicted, despite the fact that, at first glance, patients with ileocolitis or ileitis seemed to exhibit higher values of serum S100A12, compared to those with CD colitis alone.
Regulation (values) of S100A12 associated with colitis, inflammatory bowel disease, crohn's disease, ileitis and disease
6) Confidence 0.27 Published 2010 Journal BMC Gastroenterol Section Body Doc Link PMC2964606 Disease Relevance 1.66 Pain Relevance 0.29
Both UC and CD patients with active disease seemed to have higher values of S100A12 in serum, compared to IBD subjects with inactive disease but this difference was not statistically significant.
Regulation (values) of S100A12 associated with inflammatory bowel disease, crohn's disease and disease
7) Confidence 0.23 Published 2010 Journal BMC Gastroenterol Section Body Doc Link PMC2964606 Disease Relevance 1.12 Pain Relevance 0.21
Immunohistochemical staining of the removed tissues showed a strong positivity for S 100 protein, HMB 45 and MART-1 (Figure 3, 4, 5).
Regulation (positivity) of S 100 protein
8) Confidence 0.20 Published 2007 Journal World J Surg Oncol Section Body Doc Link PMC2233626 Disease Relevance 0.50 Pain Relevance 0.03
S100A12 is up regulated in psoriasis and melanoma [101].
Regulation (regulated) of S100A12 associated with psoriasis and skin cancer
9) Confidence 0.17 Published 2009 Journal J Transl Med Section Body Doc Link PMC2666642 Disease Relevance 1.08 Pain Relevance 0.20

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox